Cardiomyopathy Trial, Recruiting (NCT07563660)

Cardiomyopathy Trial, Recruiting NCT07563660 Sponsor: Istanbul University - Cerrahpasa Condition: Cardiomyopathy

Printed from Voxsanity (voxsanity.com.au) — NCT07563660 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Cardiomyopathy

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

Adults aged 18 years or older
People who have been diagnosed with a specific heart muscle condition called arrhythmogenic right ventricular cardiomyopathy (ARVC), confirmed using recognised medical diagnostic guidelines
People who are currently being monitored and followed up at the study centre
People who are able to understand what the study involves and are willing to sign a consent form

Who may not be able to join:

People who have a history of cancer
People with severely reduced kidney function
People with severely reduced liver function
People who are pregnant or currently breastfeeding
People who have previously had a specific type of medical imaging scan called a 68Ga-DOTA-SA-FAPI PET/CT scan
People who are unable or unwilling to sign a written consent form
People who have any medical, personal, or practical circumstances that the trial doctors believe could interfere with taking part in the study, interpreting the scans, or completing all required follow-up visits (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 27 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +90 555 623 2606

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07563660

Sponsor: Istanbul University - Cerrahpasa

Phase: Not Applicable

Status: Recruiting

Condition: Cardiomyopathy

Trial contact: +90 555 623 2606

More information: https://clinicaltrials.gov/study/NCT07563660

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

Adults aged 18 years or older
People who have been diagnosed with a specific heart muscle condition called arrhythmogenic right ventricular cardiomyopathy (ARVC), confirmed using recognised medical diagnostic guidelines
People who are currently being monitored and followed up at the study centre
People who are able to understand what the study involves and are willing to sign a consent form

Who may not be able to join:

People who have a history of cancer
People with severely reduced kidney function
People with severely reduced liver function
People who are pregnant or currently breastfeeding
People who have previously had a specific type of medical imaging scan called a 68Ga-DOTA-SA-FAPI PET/CT scan
People who are unable or unwilling to sign a written consent form
People who have any medical, personal, or practical circumstances that the trial doctors believe could interfere with taking part in the study, interpreting the scans, or completing all required follow-up visits (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 27 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Istanbul University - Cerrahpasa

Registry

ClinicalTrials.gov

Start date

16 April 2025

Est. completion

25 August 2026

Where this trial is recruiting

Turkey (Türkiye)

Primary endpoints

Myocardial 68Ga-DOTA-SA-FAPI Uptake on PET/CT

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov